AZNASTRAZENECA PLC

Nasdaq astrazeneca.com


$ 82.85 $ -2.75 (-3.21 %)    

Thursday, 05-Sep-2024 15:17:39 EDT
QQQ $ 459.86 $ 0.43 (0.09 %)
DIA $ 407.95 $ -1.96 (-0.48 %)
SPY $ 548.56 $ -1.34 (-0.24 %)
TLT $ 99.56 $ 0.56 (0.57 %)
GLD $ 232.35 $ 1.92 (0.83 %)
$ 83
$ 84.02
$ 82.85 x 100
$ 82.87 x 400
$ 82.45 - $ 84.02
$ 58.30 - $ 87.68
7,754,798
na
128.67B
$ 0.55
$ 7.52
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 astrazeneca-in-trouble-for-employee-detentions-in-china-over-illegal-activities

Chinese police detain AstraZeneca employees over alleged data privacy breaches and unlicensed drug imports amid an anti-corrupt...

 china-detains-astrazeneca-staff-in-data-drug-import-probes---bloomberg

https://www.bloomberg.com/news/articles/2024-09-05/china-detains-astrazeneca-staff-in-data-drug-import-probes

Core News & Articles

- Reuters 

 despite-medicare-negotiations-americans-may-still-have-to-pay-more-for-prescription-drugs

Despite Medicare's first-ever negotiated drug prices under the Inflation Reduction Act, U.S. costs remain significantly hig...

 astrazeneca-plans-presentations-across-its-portfolio-and-pipeline-at-the-iaslc-2024-world-conference-on-lung-cancer-and-esmo-congress

Across the two meetings, more than 130 abstracts will feature 17 approved and potential new medicines from AstraZeneca includin...

 astrazeneca-threatens-to-move-vaccine-production-amid-reduced-state-support

AstraZeneca may relocate its vaccine manufacturing site from Merseyside to Philadelphia as the UK government considers slashing...

 ozempic-and-wegovy-linked-to-increased-suicidal-thoughts-in-observational-study-but-results-are-contested

A recent study in JAMA Network Open raises concerns about a potential link between GLP-1 drugs Ozempic and Wegovy and an increa...

Core News & Articles

- Reuters 

 johnson--johnson-strikes-17b-deal-to-acquire-heart-tech-innovator-v-wave

Johnson & Johnson to acquire V-Wave for $600 million with potential $1.1 billion in milestone payments. Deal boosts JNJ Med...

Core News & Articles

Daiichi Sankyo and AstraZeneca's ENHERTU has now been granted eight Breakthrough Therapy Designations with latest based o...

 fda-approves-astrazenecas-blockbuster-cancer-drug-imfinzi-in-combination-with-chemo-for-non-small-cell-lung-cancer

FDA approves AstraZeneca's Imfinzi with chemotherapy for early-stage lung cancer, based on pivotal AEGEAN trial. Imfinzi sh...

 astrazenecas-578m-vaccine-plant-in-doubt-as-uk-government-cuts-funding

AstraZeneca is raising concerns that a manufacturing site could be relocated to France, putting an investment in jeopardy.

Core News & Articles

Imfinzi plus chemotherapy as 1st-line treatment followed by Lynparza and Imfinzi has been approved for patients with mismatch r...

 struggling-covid-19-vaccines-from-astrazeneca-biontechpfizer-moderna-cut-incidence-of-arterial-thromboses-that-cause-heart-attacks-strokes-british-study-shows

COVID-19 vaccinations could lower the incidence of heart attacks and strokes, according to a new study by UK universities. The ...

 new-european-regulations-could-hinder-rare-disease-treatments-pharma-industry-raises-concerns-over-stricter-clinical-trial-rules

Pharmaceutical companies, researchers, and patient groups are voicing concerns over new EU regulations that could hinder rare d...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION